Sight Sciences Q3 2026 Results: Net Loss of $6.81M, Loss Narrows
Sight Sciences, Inc. reported total assets of $104.9 million as of September 30, 2026, a decrease from $115.3 million at the end of 2025, primarily driven by a reduction in cash and cash equivalents. The company continues to focus on its Interventional Glaucoma and Dry Eye products while implementing cost-reduction plans to manage operating expenses and net losses.
- Key figure
- Net loss $6.81M